|
1
|
Asif M: The prevention and control the
type-2 diabetes by changing lifestyle and dietary pattern. J Educ
Health Promot. 3:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Riobo Servan P: Obesity and diabetes. Nutr
Hosp. 28:138–143. 2013.PubMed/NCBI
|
|
3
|
Xiao J, Chen T and Cao H: Flavonoid
glycosylation and biological benefits. Biotechnol Adv. May
22–2014.Epub ahead of print. View Article : Google Scholar
|
|
4
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lahmy R, Soleimani M, Sanati MH, Behmanesh
M, Kouhkan F and Mobarra N: Pancreatic islet differentiation of
human embryonic stem cells by microRNA overexpression. J Tissue Eng
Regen Med. 10:527–534. 2016. View Article : Google Scholar
|
|
6
|
Stefani G and Slack FJ: Small non-coding
RNAs in animal development. Nat Rev Mol Cell Biol. 9:219–230. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi Y and Jin Y: MicroRNA in cell
differentiation and development. Sci China C Life Sci. 52:205–211.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carrington JC and Ambros V: Role of
microRNAs in plant and animal development. Science. 301:336–338.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kaviani M, Azarpira N, Karimi MH and
Al-Abdullah I: The role of microRNAs in islet β-cell development.
Cell Biol Int. 40:1248–1255. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dalgaard LT and Eliasson L: An
‘alpha-beta’ of pancreatic islet microribonucleotides. Int J
Biochem Cell Biol. 88:208–219. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shewade YM, Umrani M and Bhonde RR:
Large-scale isolation of islets by tissue culture of adult mouse
pancreas. Transplant Proc. 31:1721–1723. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
O’Connell RM, Taganov KD, Boldin MP, Cheng
G and Baltimore D: MicroRNA-155 is induced during the macrophage
inflammatory response. Proc Natl Acad Sci USA. 104:1604–1609. 2007.
View Article : Google Scholar
|
|
13
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
Nikolai VK and Steve JU: Association of
RNA polymerase complexes of the parasitic protozoan cryptosporidium
parvum with virus-like particles: Heterogeneous system. J Virol.
74:5788–5795. 2000. View Article : Google Scholar
|
|
16
|
Sebastiani G, Po A, Miele E, Ventriglia G,
Ceccarelli E, Bugliani M, Marselli L, Marchetti P, Gulino A,
Ferretti E and Dotta F: MicroRNA-124a is hyperexpressed in type 2
diabetic human pancreatic islets and negatively regulates insulin
secretion. Acta Diabetol. 52:523–530. 2015. View Article : Google Scholar
|
|
17
|
da Silva Xavier G, Loder MK, McDonald A,
Tarasov AI, Carzaniga R, Kronenberger K, Barg S and Rutter GA:
TCF7L2 regulates late events in insulin secretion from pancreatic
islet beta-cells. Diabetes. 58:894–905. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Weir GC and Bonner-Weir S: Sleeping islets
and the relationship between β-cell mass and function. Diabetes.
60:2018–2019. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kahn SE: The relative contributions of
insulin resistance and beta-cell dysfunction to the pathophysiology
of type 2 diabetes. Diabetologia. 46:3–19. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maris M, Ferreira GB, D’Hertog W, Cnop M,
Waelkens E, Overbergh L and Mathieu C: High glucose induces
dysfunction in insulin secretory cells by different pathways: A
proteomic approach. J Proteome Res. 9:6274–6287. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Locke JM, da Silva Xavier G, Dawe HR,
Rutter GA and Harries LW: Increased expression of miR-187 in human
islets from individuals with type 2 diabetes is associated with
reduced glucose-stimulated insulin secretion. Diabetologia.
57:122–128. 2014. View Article : Google Scholar
|
|
22
|
Ramachandran D, Roy U, Garg S, Ghosh S,
Pathak S and Kolthur-Seetharam U: Sirt1 and mir-9 expression is
regulated during glucose-stimulated insulin secretion in pancreatic
β-islets. FEBS J. 278:1167–1174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Osmai M, Osmai Y, Bang-Berthelsen CH,
Pallesen EM, Vestergaard AL, Novotny GW, Pociot F and
Mandrup-Poulsen T: MicroRNAS as regulators of beta-cell function
and dysfunction. Diabetes Metab Res Rev. 32:334–349. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thirone AC, Huang C and Klip A:
Tissue-specific roles of IRS proteins in insulin signaling and
glucose transport. Trends Endocrinol Metab. 17:72–78. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima
S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P
and Stoffel M: A pancreatic islet-specific microRNA regulates
insulin secretion. Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Baroukh N, Ravier MA, Loder MK, Hill EV,
Bounacer A, Scharfmann R, Rutter GA and Van Obberghen E:
MicroRNA-124a regulates Foxa2 expression and intracellular
signaling in pancreatic beta-cell lines. J Biol Chem.
282:19575–19588. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hu S, Wang H, Chen K, Cheng P, Gao S, Liu
J, Li X and Sun X: MicroRNA-34c downregulation
ameliorates-amyloid-β-induced synaptic failure and memory deficits
by targeting VAMP2. J Alzheimers Dis. 48:673–686. 2015. View Article : Google Scholar
|
|
30
|
Fisman EZ and Tenenbaum A: Adiponectin: A
manifold therapeutic target for metabolic syndrome, diabetes, and
coronary disease. Cardiovasc Diabetol. 13:1032014. View Article : Google Scholar
|
|
31
|
Yamauchi T, Kamon J, Ito Y, Tsuchida A,
Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, et
al: Cloning of adiponectin receptors that mediate antidiabetic
metabolic effects. Nature. 423:762–769. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yamauchi T, Iwabu M, Okada-Iwabu M and
Kadowaki T: Adiponectin receptors: A review of their structure,
function and how they work. Best Pract Res Clin Endocrinol Metab.
28:15–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Park HS, Lim JH, Kim MY, Kim Y, Hong YA,
Choi SR, Chung S, Kim HW, Choi BS, Kim YS, et al: Resveratrol
increases AdipoR1 and AdipoR2 expression in type 2 diabetic
nephropathy. J Transl Med. 14:1762016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pramanik KC, Fofaria NM, Gupta P and
Srivastava SK: CBP-mediated FOXO-1 acetylation inhibits pancreatic
tumor growth by targeting SirtT. Mol Cancer Ther. 13:687–698. 2014.
View Article : Google Scholar : PubMed/NCBI
|
